Sentiment Trading

NKGen Biotech, a clinical-stage biotech company, is pioneering groundbreaking therapies using natural killer cells to combat neurodegenerative and oncological conditions, offering new hope for patients worldwide.

NKGen Biotech has administered the first dose of its expanded autologous natural killer cell therapy, troculeucel, to a patient with mild-stage Alzheimer’s disease.